Data as of Dec 10
| -0.01 / -0.04%|
The 8 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 23.50, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a -4.51% decrease from the last price of 24.61.
The current consensus among 12 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.